Skip to content

Efficacy and safety of intrauterine infusion of umbilical cord blood mononuclear cells (UCBMCs) to improve IVF/ICSI pregnancy outcome in patients with repeated implantation failure: a randomized controlled trial.

Efficacy and safety of intrauterine infusion of umbilical cord blood mononuclear cells (UCBMCs) to improve IVF/ICSI pregnancy outcome in patients with repeated implantation failure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034364
Enrollment
Unknown
Registered
2020-07-03
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated implantation failure in IVF

Interventions

Experimental group:Intrauterine infusion of UCBMCs
Control group:No intrauterine infusion

Sponsors

The Affiliated Yantai Yuhangding Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. After more than two times of high-quality embryo transfer or cumulative transfer of more than 4 embryos without clinical pregnancy, IVF-ET is proposed to be performed again; 2. The age is 25-40 years old; 3. The uterine morphology is basically normal, no abnormal echo in the uterine cavity, no ovarian cyst, and the basic endocrine is in the normal range; 4. Patients with high-quality frozen/thawed embryo transfer cycles 5. Patients willing to accept the treatment measures of this study (including the experimental group and the control group), signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with poor ovarian function reserve or PCOS; 2. Patients who had undergone unilateral oophorectomy previously; 3. Either of the couple has abnormal karyotype; 4. Positive serological screening of torch, hepatitis B, C, human immunodeficiency virus and syphilis; 5. Any patients that was inappropriate to be treated with this regimen.

Design outcomes

Primary

MeasureTime frame
Embryo implantation rate;Clinical pregnancy rate;Abortion rates;

Secondary

MeasureTime frame
Estrogen and progesterone levels on the day of embryo transfer;Endometrial thickness on the day of transplantation;

Countries

China

Contacts

Public ContactHongchu Bao

The Affiliated Yantai Yuhangding Hospital of Qingdao University

bhch1005@126.com+86 15653561760

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026